Infliximab in refractory coeliac disease

被引：13

作者：

Chaudhary, R ^{[1
]}

Ghosh, S ^{[1
]}

机构：

[1] Hammersmith Hosp, Imperial Coll London, Gastroenterol Sect, London W12 0NN, England

来源：

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2005年 / 17卷 / 06期

关键词：

refractory coeliac disease; infliximab; T lymphocytes;

D O I：

10.1097/00042737-200506000-00002

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Coeliac disease is generally well controlled with gluten-free diet but a small proportion of patients require corticosteroids or immunomodulatory agents. Response to anti-tumour necrosis factor (anti-TNF) agents raises interesting questions about both the pathogenesis of coeliac disease and the mechanism of action of anti-TNF agents. Refractory coeliac disease poses a therapeutic challenge to clinicians and carefully selected patients may benefit from anti-TNF therapy. (c) 2005 Lippincott Williams & Wilkins.

引用

页码：603 / 604

页数：2

共 50 条

[1] Refractory coeliac disease: remission with infliximab and immunomodulators
Turner, SM
Moorghen, M
Probert, CS
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (06) : 667 - 669
[2] Successful infliximab treatment for steroid refractory coeliac disease
Arnott, IDR
Campbell, S
Dahele, A
McIntyre, M
Ghosh, S
GUT, 2001, 48 : A80 - A80
[3] Successful infliximab treatment for steroid refractory Coeliac disease
Arnott, ID
Campbell, S
Dahele, A
Macintyre, M
Ghosh, S
GASTROENTEROLOGY, 2001, 120 (05) : A392 - A392
[4] Refractory coeliac disease
Daum, S
Cellier, C
Mulder, CJJ
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (03) : 413 - 424
[5] Refractory coeliac disease
Malamut, Georgia
Cellier, Christophe
CURRENT OPINION IN ONCOLOGY, 2013, 25 (05) : 445 - 451
[6] The management of refractory coeliac disease
Woodward, Jeremy
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2013, 4 (02) : 77 - 90
[7] A Child With Refractory Coeliac Disease
Mubarak, A.
Oudshoorn, J. H.
Kneepkens, C. M. F.
Butler, J. C.
Schreurs, M. W. J.
Mulder, C. J.
Houwen, R. H. J.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 53 (02): : 216 - 218
[8] Treatment of life-threatening type I refractory coeliac disease with long-term infliximab
Costantino, G.
della Torre, A.
Lo Presti, M. A.
Caruso, R.
Mazzon, E.
Fries, W.
DIGESTIVE AND LIVER DISEASE, 2008, 40 (01) : 74 - 77
[9] Is "refractory" coeliac disease a homogeneous entity?
Rodgriues, C
Isaacson, PG
Kumar, PJ
GASTROENTEROLOGY, 2000, 118 (04) : A1133 - A1133
[10] Classification and management of refractory coeliac disease
Rubio-Tapia, Alberto
Murray, Joseph A.
GUT, 2010, 59 (04) : 547 - 557

← 1 2 3 4 5 →